PL2268292T3 - Sposób i kompozycje do leczenia raka - Google Patents

Sposób i kompozycje do leczenia raka

Info

Publication number: PL2268292T3
Authority: PL; Poland
Prior art keywords: cancer; compositions; treatment
Prior art date: 2008-03-27

Application number

PL09723788T

Other languages

English (en)

Inventor

Angelika Burger

Hans Hendriks

Bernardus Rademaker

Original Assignee

Kominox, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-27

Filing date

2009-03-24

Publication date

2018-06-29

2009-03-24 Application filed by Kominox, Inc. filed Critical Kominox, Inc.

2018-06-29 Publication of PL2268292T3 publication Critical patent/PL2268292T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL09723788T 2008-03-27 2009-03-24 Sposób i kompozycje do leczenia raka PL2268292T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US3998708P	2008-03-27	2008-03-27
US12/408,864 US20090246291A1 (en)	2008-03-27	2009-03-23	Method and compositions for treatment of cancer
PCT/US2009/038104 WO2009120697A2 (en)	2008-03-27	2009-03-24	Method and compositions for treatment of cancer
EP09723788.7A EP2268292B1 (en)	2008-03-27	2009-03-24	Method and compositions for treatment of cancer

Publications (1)

Publication Number	Publication Date
PL2268292T3 true PL2268292T3 (pl)	2018-06-29

Family

ID=41114644

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09723788T PL2268292T3 (pl)	2008-03-27	2009-03-24	Sposób i kompozycje do leczenia raka

Country Status (20)

Country	Link
US (2)	US20090246291A1 (pl)
EP (1)	EP2268292B1 (pl)
JP (2)	JP5543956B2 (pl)
KR (1)	KR101634138B1 (pl)
CN (2)	CN102046187A (pl)
AU (1)	AU2009228378B2 (pl)
BR (1)	BRPI0909164A2 (pl)
CA (1)	CA2719766C (pl)
CY (1)	CY1120536T1 (pl)
DK (1)	DK2268292T3 (pl)
ES (1)	ES2656762T3 (pl)
HU (1)	HUE036609T2 (pl)
LT (1)	LT2268292T (pl)
MX (1)	MX2010010621A (pl)
PL (1)	PL2268292T3 (pl)
PT (1)	PT2268292T (pl)
RU (1)	RU2508116C2 (pl)
SI (1)	SI2268292T1 (pl)
WO (1)	WO2009120697A2 (pl)
ZA (1)	ZA201006988B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1721615A1 (en)	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en)	2010-03-01	2016-09-20	University Of Tennessee Research Foundation	Compounds for treatment of cancer
KR20120061908A (ko) *	2009-09-10	2012-06-13	코미녹스 인코포레이티드	암 줄기세포-표적 및 약물 내성 암 치료
US8795738B2 (en) *	2009-11-12	2014-08-05	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
US11084811B2 (en)	2010-03-01	2021-08-10	Oncternal Therapeutics, Inc.	Compounds for treatment of cancer
EP2593101A4 (en) *	2010-07-18	2014-01-01	Niiki Pharma Inc	POLYTHERAPY USING RUTHENIUM COMPLEX
RU2609018C2 (ru) *	2010-08-24	2017-01-30	Джи Ти Икс, ИНК.	Соединения для лечения рака
WO2012131487A2 (en) *	2011-03-30	2012-10-04	Kominox, Inc.	Compositions and methods for the treatment of cancer
CN103826645A (zh) *	2011-05-12	2014-05-28	得克萨斯系统大学评议会	砷在癌症治疗保护中的用途
US8834938B2 (en)	2011-05-18	2014-09-16	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
WO2014152330A1 (en) *	2013-03-15	2014-09-25	Stc.Unm	Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko)	2013-03-15	2013-09-23	박상채	항암 활성 증진용 한약재 및 이의 제조방법
AU2014290012B2 (en) *	2013-07-19	2020-01-16	Onyx Therapeutics, Inc.	Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
IL265986B (en)	2016-12-01	2022-09-01	Eupharma Pty Ltd	Pharmaceutical composition comprising an alkali metal and/or an alkaline earth metal diarsenic (iii) tetraoxide and uses thereof
PE20211479A1 (es)	2018-03-22	2021-08-05	Komipharm Int Australia Pty Ltd	Composicion farmaceutica y metodo de fabricacion
CN116236505A (zh) *	2023-03-15	2023-06-09	上海市第四人民医院	三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2313201T3 (es) *	1997-10-15	2009-03-01	Polarx Biopharmaceuticals, Inc.	Composiciones farmaceuticas que comprenden trioxido de arsenico para el tratamiento de un tumor del sistema nervioso central.
JP2001522799A (ja) *	1997-11-10	2001-11-20	メモリアルスローン−ケタリングキャンサーセンター	三酸化ヒ素製剤の製造方法および三酸化ヒ素またはメラルソプロールを使用する癌の治療方法
KR20020083678A (ko) *	2001-04-28	2002-11-04	주식회사 한국미생물연구소	아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
BR0215689A (pt) *	2002-04-10	2005-02-01	Korea Microbiological Lab Ltd	Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
EP1721615A1 (en) *	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) *	2005-08-23	2012-01-17	Stc.Unm	Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
WO2009049258A1 (en) *	2007-10-12	2009-04-16	The Johns Hopkins University	Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

2009
- 2009-03-23 US US12/408,864 patent/US20090246291A1/en not_active Abandoned
- 2009-03-24 RU RU2010143893/15A patent/RU2508116C2/ru active
- 2009-03-24 EP EP09723788.7A patent/EP2268292B1/en active Active
- 2009-03-24 SI SI200931809T patent/SI2268292T1/en unknown
- 2009-03-24 CN CN2009801187686A patent/CN102046187A/zh active Pending
- 2009-03-24 WO PCT/US2009/038104 patent/WO2009120697A2/en not_active Ceased
- 2009-03-24 KR KR1020107024132A patent/KR101634138B1/ko active Active
- 2009-03-24 PT PT97237887T patent/PT2268292T/pt unknown
- 2009-03-24 MX MX2010010621A patent/MX2010010621A/es active IP Right Grant
- 2009-03-24 LT LTEP09723788.7T patent/LT2268292T/lt unknown
- 2009-03-24 JP JP2011501983A patent/JP5543956B2/ja active Active
- 2009-03-24 ES ES09723788.7T patent/ES2656762T3/es active Active
- 2009-03-24 HU HUE09723788A patent/HUE036609T2/hu unknown
- 2009-03-24 DK DK09723788.7T patent/DK2268292T3/en active
- 2009-03-24 AU AU2009228378A patent/AU2009228378B2/en not_active Ceased
- 2009-03-24 PL PL09723788T patent/PL2268292T3/pl unknown
- 2009-03-24 CN CN201510355863.5A patent/CN104997808A/zh active Pending
- 2009-03-24 CA CA2719766A patent/CA2719766C/en active Active
- 2009-03-24 BR BRPI0909164A patent/BRPI0909164A2/pt not_active Application Discontinuation
2010
- 2010-09-30 ZA ZA2010/06988A patent/ZA201006988B/en unknown
2014
- 2014-03-10 JP JP2014046212A patent/JP2014101387A/ja not_active Withdrawn
2017
- 2017-06-02 US US15/613,020 patent/US20180055812A1/en not_active Abandoned
2018
- 2018-03-09 CY CY20181100285T patent/CY1120536T1/el unknown

Also Published As

Publication number	Publication date
LT2268292T (lt)	2018-03-26
ZA201006988B (en)	2012-05-30
DK2268292T3 (en)	2018-03-12
AU2009228378B2 (en)	2014-07-17
RU2508116C2 (ru)	2014-02-27
EP2268292A2 (en)	2011-01-05
WO2009120697A3 (en)	2010-02-18
CN102046187A (zh)	2011-05-04
HUE036609T2 (hu)	2018-07-30
JP5543956B2 (ja)	2014-07-09
EP2268292A4 (en)	2011-05-11
ES2656762T3 (es)	2018-02-28
CA2719766A1 (en)	2009-10-01
WO2009120697A2 (en)	2009-10-01
PT2268292T (pt)	2018-02-19
CY1120536T1 (el)	2019-07-10
JP2014101387A (ja)	2014-06-05
CA2719766C (en)	2017-10-31
RU2010143893A (ru)	2012-05-10
US20180055812A1 (en)	2018-03-01
AU2009228378A1 (en)	2009-10-01
MX2010010621A (es)	2011-04-05
CN104997808A (zh)	2015-10-28
BRPI0909164A2 (pt)	2016-06-21
EP2268292B1 (en)	2017-12-27
SI2268292T1 (en)	2018-03-30
US20090246291A1 (en)	2009-10-01
KR101634138B1 (ko)	2016-06-28
KR20110009664A (ko)	2011-01-28
JP2011515481A (ja)	2011-05-19
WO2009120697A4 (en)	2010-04-15

Publication	Publication Date	Title
ZA201006988B (en)	2012-05-30	Method and compositions for treatment of cancer
IL267342A (en)	2019-08-29	Antibodies and preparations containing them for the treatment of cancer
IL218987A0 (en)	2012-06-28	Methods and compositions for treating cancer
PL2340042T3 (pl)	2015-01-30	Sposoby i kompozycje do leczenia raka
PL2200431T3 (pl)	2017-01-31	Nowe kompozycje i metody służące leczeniu raka
SG10201510152RA (en)	2016-01-28	Diagnostic methods and compositions for treatment of cancer
SG10201402491YA (en)	2014-07-30	Methods and compositions for diagnosis and treatment of cancer
PL2350273T3 (pl)	2016-10-31	Kompozycje modyfikowanych ludzkich arginaz i sposoby leczenia nowotworu złośliwego
EP2429584A4 (en)	2013-02-20	TREATMENT PROCEDURE AND COMPOSITIONS
IL214349A0 (en)	2011-09-27	Compositions and methods for the treatment of cancer
IL199689A0 (en)	2010-04-15	Compounds and method for treatment of cancer
EP2176406A4 (en)	2011-10-19	COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2225226A4 (en)	2012-03-14	COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2515652A4 (en)	2014-11-26	COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL196727A0 (en)	2011-08-01	Composition and method for treatment of tumors
GB0808326D0 (en)	2008-06-18	Compositions and methods for the treatment of fybromyalgia
HUE054409T2 (hu)	2021-09-28	Új kompozíciók és eljárások rák kezelésére